Suzuki Haruhisa, Oda Ichiro, Sekiguchi Masau, Abe Seiichiro, Nonaka Satoru, Yoshinaga Shigetaka
Endoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Turk J Gastroenterol. 2014 Dec;25(6):619-23. doi: 10.5152/tjg.2014.14077.
BACKGROUND/AIMS: Endoscopic submucosal dissection (ESD) was originally developed in 1995 using an insulation-tipped diathermic knife (Olympus, Tokyo, Japan) to achieve en-bloc resection of early gastric cancer (EGC). It has been suggested that advances in endoscopic devices and medical equipment, such as the high-frequency generator (1999) and hemostatic forceps (2000), and procedural improvements including post-ESD preventive coagulation of visible vessels in the resection area (2003) led to further progress of ESD; therefore, we investigated the actual process of technical stabilization of gastric ESD.
A total of 1,713 consecutive patients with solitary differentiated-type EGC at initial onset underwent ESD at our hospital from 1995 to 2006. We retrospectively assessed ESD outcomes for all patients by dividing them into three chronological periods: 1995-1998 (1st period; 57 patients), 1999-2002 (2nd period; 563 patients), and 2003-2006 (3rd period; 1,093 patients).
The en-bloc resection, intraoperative bleeding, and delayed bleeding in the 1st/2nd/3rd period were 52.6%/94.7%/99.3% (1st vs. 2nd, p<0.01; 2nd vs. 3rd, p<0.01), 8.8%/7.1%/1.6% (1st vs. 2nd, no significant difference; 2nd vs. 3rd, p<0.01), and 15.8%/7.6%/3.3% (1st vs. 2nd, p<0.05; 2nd vs. 3rd, p<0.01), respectively.
Gastric ESD has stabilized technically following advances in endoscopic devices and medical equipment together with procedural improvements.
背景/目的:内镜黏膜下剥离术(ESD)最初于1995年采用绝缘头电刀(日本东京奥林巴斯公司)开展,以实现早期胃癌(EGC)的整块切除。有人认为,内镜设备和医疗器材的进步,如高频发生器(1999年)和止血钳(2000年),以及包括ESD术后对切除区域可见血管进行预防性凝血等操作改进(2003年),推动了ESD的进一步发展;因此,我们对胃ESD技术稳定的实际过程进行了研究。
1995年至2006年,我院共有1713例初发的孤立性分化型EGC患者连续接受了ESD治疗。我们将所有患者按时间顺序分为三个时期进行回顾性评估:1995 - 1998年(第1期;57例患者)、1999 - 2002年(第2期;563例患者)和2003 - 200年(第3期;1093例患者)。
第1/2/3期的整块切除率、术中出血率和迟发性出血率分别为52.6%/94.7%/99.3%(第1期与第2期比较,p<0.01;第2期与第3期比较,p<0.01)、8.8%/7.1%/1.6%(第1期与第2期比较,无显著差异;第2期与第3期比较,p<0.01)和15. /7.6%/3.3%(第1期与第2期比较,p<0.05;第2期与第3期比较,p<0.01)。
随着内镜设备和医疗器材的进步以及操作的改进,胃ESD在技术上已趋于稳定。